These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8765039)
1. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Stryhn A; Pedersen LO; Romme T; Holm CB; Holm A; Buus S Eur J Immunol; 1996 Aug; 26(8):1911-8. PubMed ID: 8765039 [TBL] [Abstract][Full Text] [Related]
2. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163 [TBL] [Abstract][Full Text] [Related]
3. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
4. A pattern search method for putative anchor residues in T cell epitopes. Hobohm U; Meyerhans A Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684 [TBL] [Abstract][Full Text] [Related]
5. Characterization of peptide binding to the murine MHC class I H-2Kk molecule. Sequencing of the bound peptides and direct binding of synthetic peptides to isolated class I molecules. Brown EL; Wooters JL; Ferenz CR; O'Brien CM; Hewick RM; Herrmann SH J Immunol; 1994 Oct; 153(7):3079-92. PubMed ID: 7522249 [TBL] [Abstract][Full Text] [Related]
6. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207 [TBL] [Abstract][Full Text] [Related]
7. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar). Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244 [TBL] [Abstract][Full Text] [Related]
8. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. Mata M; Travers PJ; Liu Q; Frankel FR; Paterson Y J Immunol; 1998 Sep; 161(6):2985-93. PubMed ID: 9743362 [TBL] [Abstract][Full Text] [Related]
9. A molecular basis for how a single TCR interfaces multiple ligands. Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402 [TBL] [Abstract][Full Text] [Related]
10. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria. Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385 [TBL] [Abstract][Full Text] [Related]
11. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex. Vasmatzis G; Cornette J; Sezerman U; DeLisi C J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503 [TBL] [Abstract][Full Text] [Related]
12. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811 [TBL] [Abstract][Full Text] [Related]
13. The interaction of antigenic peptides with the H-2Kd MHC class I molecule. Maryanski JL; Lüthy R; Romero P; Healy F; Drouet C; Casanova JL; Jaulin C; Kourilsky P; Corradin G Semin Immunol; 1993 Apr; 5(2):95-104. PubMed ID: 8504219 [TBL] [Abstract][Full Text] [Related]
14. MHC class I/peptide interactions: binding specificity and kinetics. Margulies DH; Corr M; Boyd LF; Khilko SN J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252 [TBL] [Abstract][Full Text] [Related]
15. Circular dichroism determination of class I MHC-peptide equilibrium dissociation constants. Morgan CS; Holton JM; Olafson BD; Bjorkman PJ; Mayo SL Protein Sci; 1997 Aug; 6(8):1771-3. PubMed ID: 9260291 [TBL] [Abstract][Full Text] [Related]
16. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif. Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035 [TBL] [Abstract][Full Text] [Related]
17. Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains. Elliott T; Elvin J; Cerundolo V; Allen H; Townsend A Eur J Immunol; 1992 Aug; 22(8):2085-91. PubMed ID: 1639105 [TBL] [Abstract][Full Text] [Related]
18. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31. Wu S; Gorski J; Eckels DD; Newton-Nash DK J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. van der Burg SH; Visseren MJ; Brandt RM; Kast WM; Melief CJ J Immunol; 1996 May; 156(9):3308-14. PubMed ID: 8617954 [TBL] [Abstract][Full Text] [Related]
20. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin. Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]